Chih-Jian Lih Selected Research

Chih-Jian Lih Research Topics

11	Neoplasms (Cancer) 01/2021 - 08/2006
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2017 - 02/2014
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2016
1	Sudden Death 01/2019
1	Neuroendocrine Carcinoma 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Anemia 08/2017
1	Leukopenia 08/2017
1	Neutropenia 08/2017
1	Thrombocytopenia (Thrombopenia) 08/2017
1	Ovarian Neoplasms (Ovarian Cancer) 04/2015
1	Fallopian Tube Neoplasms 04/2015
1	Adenocarcinoma 01/2015
1	Leukemia 02/2014
1	Lymphoma (Lymphomas) 02/2014
1	Arthritis (Polyarthritis) 10/2012
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2012
1	Macrophage Activation Syndrome 03/2012
1	Inflammation (Inflammations) 07/2008
1	Prostatic Neoplasms (Prostate Cancer) 08/2006

6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2015
3	Biological ProductsIBA 01/2018 - 10/2012
2	veliparibIBA 01/2021 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2006
2	ibrutinibIBA 01/2019 - 08/2015
1	trametinibIBA 01/2021
1	Everolimus FDA Link 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	adavosertibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2020
1	Co-Repressor ProteinsIBA 10/2020
1	TensinsIBA 10/2020
1	MutL Protein Homolog 1IBA 10/2020
1	MutS ProteinsIBA 10/2020
1	obinutuzumabIBA 01/2019
1	Chlorambucil (Leukeran)FDA Link 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2017
1	Rituximab (Mabthera)FDA Link 08/2017
1	Lenalidomide (CC 5013)FDA Link 08/2017
1	Gemcitabine FDA Link 08/2017
1	Etoposide (VP 16)FDA LinkGeneric 08/2017
1	Messenger RNA (mRNA)IBA 04/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2015
1	ParaffinIBA 02/2014
1	carboxyl radical (COO-)IBA 02/2014
1	Formaldehyde (Formol)FDA Link 02/2014
1	Syntex adjuvant formulationIBA 10/2012
1	Interleukin-4 (Interleukin 4)IBA 10/2012
1	Interleukin-10 (Interleukin 10)IBA 10/2012
1	CytokinesIBA 03/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008
1	taxaneIBA 08/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2006
1	Thrombospondin 1IBA 08/2006